Adverse Events with 4 Months of Rifampin Therapy or 9 Months of Isoniazid Therapy for Latent Tuberculosis Infection-Reference-Cited by-同舟云学术

Adverse Events with 4 Months of Rifampin Therapy or 9 Months of Isoniazid Therapy for Latent Tuberculosis Infection

Published:2008-11-18 Issue:10 Volume:149 Page:689
ISSN:0003-4819
Container-title:Annals of Internal Medicine
language:en
Short-container-title:Ann Intern Med

Author:

Menzies Dick¹,Long Richard¹,Trajman Anete¹,Dion Marie-Jose¹,Yang Jae¹,Al Jahdali Hamdan¹,Memish Ziad¹,Khan Kamran¹,Gardam Michael¹,Hoeppner Vernon¹,Benedetti Andrea¹,Schwartzman Kevin¹

Affiliation:

1. From the Montreal Chest Institute, McGill University, Montreal, Quebec, Canada; University of Alberta, Edmonton, Alberta, Canada; University of Toronto and St. Michael's Hospital, Toronto, Ontario, Canada; University of Saskatchewan, Saskatoon, Saskatchewan, Canada; Gama Filho University, Rio de Janeiro, Brazil; and King Abdulaziz Medical City, King Abdulaziz Bin Saud University, Riyadh, Saudi Arabia.

Publisher

American College of Physicians

Subject

General Medicine,Internal Medicine

Cited by 193 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High-dose, short-duration versus standard rifampicin for tuberculosis preventive treatment: a partially blinded, three-arm, non-inferiority, randomised, controlled trial;The Lancet Respiratory Medicine;2024-06

2. Tuberculosis: estado actual;Revista Médica Clínica Las Condes;2024-05

3. Genotyped Cluster Investigations versus Standard Contact Tracing: Comparative Impact on Latent Tuberculosis Infection Cascade of Care in a Low-Incidence Region;2024-04-25

4. Risk factors for poor engagement with a smart pillbox adherence intervention among persons on tuberculosis treatment in Ethiopia;BMC Public Health;2023-10-14

5. Efficacy of anti-tuberculosis drugs for the treatment of latent tuberculosis infection: a systematic review and network meta-analysis;Scientific Reports;2023-09-27